The ability to resist non-economic threats is a key factor in the Far Easts appeal to investors. The Asia-Pacific Region regularly faces the threat of epidemics, which not only impedes regional integration and stable socioeconomic development but also results in significant financial losses. Over the last few years, the negative effect of such threats can be measured in billions of dollars. In the Far East, the increased cross-border movement of people and goods requires further improvement of techniques for managing health risks. The existing Russian system for preventing and responding to the threat of dangerous infectious diseases has shown itself to be effective. Given the border-crossing nature of epidemics, a regional approach to combating acute threats needs to be developed (the Zika virus, Ebola, new strains of flu), as well as in addressing HIV, tuberculosis, dengue fever, etc. Losses resulting from health threats must be reduced, which will not only increase returns on investment but also improve quality of life. Policy decisions in this area have already been made by leaders within an array of multilateral and international organizations (EAS, APEC, ASEAN). The time has come for practical measures. What risks does the region currently face from epidemics? How much do infectious diseases cost investors and economies? What are the prospects for developing a regional system to manage health and epidemiological risks? What would its future components be? What measures exist for helping developing nations within the Asia-Pacific Region create basic epidemic warning and response capabilities, and what is Russias role? Inclusive investment: could investment in healthcare reduce losses caused by epidemics?